InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
1
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-30.3%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
No signal scores available.
Discover the detailed record of transactions filed by Cavanaugh Stefanie L., Chief Financial Officer. Officer active across 3 companies, notably Apollo Endosurgery, Inc.. Cumulatively, 9 filings have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €23k. Activity tracked since 7 July 2021. The latest transaction was filed on 4 June 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Cavanaugh Stefanie L.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
5,937 shares0Common StockSEC:0001641172-25-013811:0
5,938 shares0Common StockSEC:0001641172-25-002184:0
5,937 shares0Common StockSEC:0001688530-25-000001:0
5,938 shares0Common StockSEC:0001688530-24-000002:0
16,804 shares0Common StockSEC:0000950170-24-096254:0
3,268 sharesCommon StockSEC:0001688530-24-000001:0
6,281 shares@ US$3.98100.0% of flowCommon stockSEC:0001688530-23-000002:0
Canonical exit: 22 Oct 2023 (T+90)
28,623 shares0Common StockSEC:0001688530-23-000001:0
91 shares0Common StockSEC:0001251769-21-000092:0
9 of 9 declarations
About Cavanaugh Stefanie L.
Stefanie L. Cavanaugh is Directeur Financier and also serves as Director at Aspira Women's Health Inc. and as CFO, Treasurer, Secretary at Apollo Endosurgery, Inc. She has 9 filings in total, and among the recent sampled filings the period runs from 2021-07-07 to 2025-06-05, with EUR 22596 of buys and EUR 0 of sells, and the most frequent transaction nature being Levée d'options.
